Melanoma News

• ICIs in Melanoma: Predicting Immune-related Adverse Events Melanoma histopathology predicted which patients were most likely to develop immune-related adverse events while taking checkpoint inhibitors.
  Medscape Medical News, December 26, 2023
• Study Eyes Melanoma Characteristics in AI/AN Population The primary site with the highest mortality risk was the trunk.
  Medscape Medical News, December 11, 2023
• How the Microbiome Influences the Success of Cancer Therapy Microbial diversity affects whether a tumor grows, leads to inflammation, develops immune escape mechanisms, or develops therapeutic resistance, said an internal medicine specialist.
  Medscape Medical News, December 04, 2023
• MSWS 2023 New Tools Available to Help Diagnose Skin Cancer Emerging technologies aim to improve skin cancer diagnosis without biopsies.
  Medscape Medical News, December 03, 2023
• Dermatopathologists Make More Higher-Grade Dx of Lesions The findings "could in part play a role in the rising incidence of early-stage melanoma with low risk of progression or patient morbidity, thereby contributing to increasing rates of overdiagnosis."
  MDedge News, November 13, 2023
• Incipient Ulceration May Affect Prognosis in Primary Melanoma Assigning a lower-risk pathologic T stage to such melanomas may not be appropriate, the study authors conclude.
  Medscape Medical News, November 09, 2023
• Actinic Keratoses May Predict Skin Cancers in Older Adults A retrospective cohort study showed increased absolute and relative risks for skin cancers up to 5 years after an AK diagnosis.
  Medscape Medical News, November 09, 2023
• Assistance Dogs Benefit Patients With Various Diseases Trained dogs cannot only help patients with disabilities but also detect SARS-CoV-2 infection, cancer, and imminent epileptic seizures.
  Medscape Medical News, November 08, 2023
• ESMO 2023 Benefits of Tebentafusp in Uveal Melanoma Last 3 Years A new analysis suggests that the treatment's benefits for overall survival endures for at least 36 months.
  Medscape Medical News, November 07, 2023
• EADV 2023 AI Can Flag Skin Cancer With Near-Perfect Accuracy Artificial intelligence could help dermatologists catch skin cancer faster and triage patients.
  Medscape Medical News, October 20, 2023
• New Trials in Colorectal Cancer: Could Your Patient Benefit? Maybe one of your patients can join a new clinical trial in colorectal cancer.
  Medscape Medical News, October 19, 2023
• ASTRO 2023 ctDNA Pre-Radiation Predicts Oligometastatic NSCLC Survival Measuring ctDNA levels before radiotherapy predicted PFS and overall survival, and can help determine the patients most likely to benefit from consolidation radiotherapy vs systemic therapy.
  Medscape Medical News, October 09, 2023
• ATA 2023 Triple Therapy Boosts Anaplastic Thyroid Cancer Survival With the neoadjuvant regimen of pembrolizumab added to dabrafenib and trametinib, survival in BRAF-mutated forms of the highly aggressive cancer can go from months to more than 5 years.
  Medscape Medical News, September 29, 2023
• These Adverse Events Linked to Improved Cancer Prognosis Cutaneous immune-related adverse events are associated with a better prognosis among patients with cancer who receive immune checkpoint inhibitors, new research suggests.
  Medscape Medical News, September 28, 2023
• Does the Number of Primary Melanomas Affect Survival? Detecting melanoma at an early stage remains the biggest influence on mortality after one or more melanomas are diagnosed, according to investigators.
  Medscape Medical News, September 21, 2023
• Therapeutic Vaccine Shows Promise in Treating Lung Cancer In a study that did not achieve its recruitment goal, the patients who benefited most from the vaccine had previously responded to immunotherapy.
  Medscape Medical News, September 19, 2023
• Does Adding Ipilimumab to Nivolumab Improve Cancer Outcomes? Nivolumab alone may offer equivalent clinical outcomes and lower toxicity than nivolumab plus ipilimumab in many advanced cancers other than melanoma, a new meta-analysis suggests.
  Medscape Medical News, September 18, 2023
• SOHO 2023 Debate: Should Smoldering Myeloma Be Treated? The two experts based their arguments largely on the same two studies, the only randomized trials to tackle the issue to date.
  MDedge News, September 14, 2023
• High Rate of Subsequent Cancers in Merkel Cell Carcinoma In this cohort study, researchers identified 6146 patients from 17 registries of the SEER Program who had been diagnosed with a first primary cutaneous Merkel cell carcinoma between 2000 and 2018.
  MDedge News, September 14, 2023
• Pinpointing Key Features of Gut Dysbiosis in Melanoma Fecal microbiota profiles differ among patients with melanoma and those without as well as between patients with early stage and late-stage disease, new data suggest.
  Medscape Medical News, September 01, 2023
• Neoadj T-VEC May Improve Survival in Resectable Melanoma Offering talimogene laherparepvec before surgery compared with surgery alone could improve event-free as well as overall survival in patients with advanced resectable melanoma, a new analysis suggests.
  Medscape Medical News, August 22, 2023
• Immune Issues After Adjuvant Anti–PD-1 Therapy in Melanoma Chronic immune-related adverse events often persist years after adjuvant anti–PD-1 immunotherapy for high-risk melanoma and may require prolonged monitoring and management, researchers say.
  Medscape Medical News, August 10, 2023
• Are AI-Powered Skin-Check Tools on the Horizon? Primary care might be the first setting where AI-driven tools allow for broader access to effective melanoma screening, amid continuing challenges in developing consumer apps for this purpose.
  Medscape Medical News, August 01, 2023